These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17051236)

  • 21. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The road from obesity to type 2 diabetes.
    Ioannidis I
    Angiology; 2008; 59(2 Suppl):39S-43S. PubMed ID: 18505743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
    Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
    Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation.
    Staiger K; Staiger H; Weigert C; Haas C; Häring HU; Kellerer M
    Diabetes; 2006 Nov; 55(11):3121-6. PubMed ID: 17065351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of coronary dysfunction in obesity and insulin resistance.
    Knudson JD; Dincer UD; Bratz IN; Sturek M; Dick GM; Tune JD
    Microcirculation; 2007; 14(4-5):317-38. PubMed ID: 17613805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans.
    Florian JP; Pawelczyk JA
    Clin Sci (Lond); 2009 Oct; 118(1):61-9. PubMed ID: 19426144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gestational diabetes, pregnancy hypertension, and late vascular disease.
    Carpenter MW
    Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats.
    Chanséaume E; Tardy AL; Salles J; Giraudet C; Rousset P; Tissandier A; Boirie Y; Morio B
    Obesity (Silver Spring); 2007 Jan; 15(1):50-9. PubMed ID: 17228031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
    Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
    Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
    Ragab A; Abousamra NK; Higazy A; Saleh O
    Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond.
    Stepp DW
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):407-14. PubMed ID: 16700872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and blood pressure circadian variation in an obese hypertensive population.
    Diamantopoulos EJ; Andreadis E; Tsourous G; Katsanou P; Georgiopoulos D; Fotia M; Antoniou A; Raptis SA
    Clin Exp Hypertens; 2006 Oct; 28(7):625-30. PubMed ID: 17060061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
    Han SH; Quon MJ; Koh KK
    Curr Opin Lipidol; 2007 Feb; 18(1):58-65. PubMed ID: 17218834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure.
    Aggoun Y; Farpour-Lambert NJ; Marchand LM; Golay E; Maggio AB; Beghetti M
    Eur Heart J; 2008 Mar; 29(6):792-9. PubMed ID: 18245115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.